NewAmsterdam Pharma Company
NAMS
#4070
Rank
ยฃ1.79 B
Marketcap
ยฃ19.43
Share price
0.69%
Change (1 day)
155.48%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ47.34 Million

According to NewAmsterdam Pharma Company's latest financial reports the company's total liabilities are ยฃ47.34 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NewAmsterdam Pharma Company - Total liabilities on balance sheet (from 2023 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ46.07 M7.31%
2022-12-31ยฃ42.94 M352.46%
2021-12-31ยฃ9.49 M-33.24%
2020-12-31ยฃ14.21 M